Impact Biomedical (IBO) Cash & Equivalents (2022 - 2026)
Impact Biomedical (IBO) posted Cash & Equivalents of $20000.0 for Q1 2026, up 566.67% on a QoQ basis from $3000.0 in Q4 2025, and down 98.48% year-over-year from $1.3 million in Q1 2025.
Impact Biomedical (IBO) Cash & Equivalents (2022 - 2026) Analysis & Trends
Impact Biomedical's Cash & Equivalents history runs 5 years deep, the most recent figure standing at $20000.0 for Q1 2026.
- Quarterly Cash & Equivalents fell 98.48% year-over-year to $20000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $20000.0 (down 98.48% YoY) and the FY2025 annual result came in at $3000.0, down 99.85% from the prior year.
- Cash & Equivalents was $20000.0 for Q1 2026 at Impact Biomedical, up from $3000.0 in the prior quarter.
- Across five years, Cash & Equivalents topped out at $2.0 million in Q4 2024 and bottomed at $1000.0 in Q3 2023.
- A 5-year average of $335100.0 and a median of $2500.0 in 2022 frame the typical range for Cash & Equivalents.
- Annual changes were most pronounced in 2024 — Cash & Equivalents surged 199800.0% — and 2025, when it slumped 99.85%.
- Impact Biomedical's Cash & Equivalents stood at $2000.0 in 2022, then plunged by 50.0% to $1000.0 in 2023, then jumped by 199800.0% to $2.0 million in 2024, then slumped by 99.85% to $3000.0 in 2025, then jumped by 566.67% to $20000.0 in 2026.
- Business Quant data shows IBO's Cash & Equivalents at $20000.0 in Q1 2026, $3000.0 in Q4 2025, and $1.3 million in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 82.45 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 61.40 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 4.79 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 32.26 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 5.49 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 2.96 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 3.58 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 440.94 Mn |
| 10 | Impact Biomedical | 47.44 Mn | 50.67 Mn | - | 20,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 20,000.00 |
| Dec 31, 2025 | 3,000.00 |
| Mar 31, 2025 | 1.32 Mn |
| Dec 31, 2024 | 2.00 Mn |
| Jun 30, 2024 | 2,000.00 |
| Mar 31, 2024 | 2,000.00 |
| Dec 31, 2023 | 1,000.00 |
| Sep 30, 2023 | 1,000.00 |
| Jun 30, 2023 | 3,000.00 |
| Dec 31, 2022 | 2,000.00 |